mupirocin and Paronychia

mupirocin has been researched along with Paronychia* in 2 studies

Other Studies

2 other study(ies) available for mupirocin and Paronychia

Article	Year
Antibiotic Overuse and Paronychia: A Teachable Moment. JAMA internal medicine, 2016, Volume: 176, Issue:1 Topics: Administration, Cutaneous; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Drug Eruptions; Female; Humans; Inappropriate Prescribing; Mupirocin; Paronychia; Triamcinolone; Trimethoprim, Sulfamethoxazole Drug Combination	2016
Paronychia associated with antiretroviral therapy. The British journal of dermatology, 1999, Volume: 140, Issue:6 We report six HIV patients who developed painful periungual inflammation of several nails during treatment with the antiretroviral drugs indinavir and lamivudine. The lesions appeared 2-12 months after starting treatment. The occurrence of paronychia in HIV patients has recently been reported in two groups of patients receiving either indinavir or lamivudine. Dermatologists should be aware of this recently reported and probably not uncommon side-effect of antiretroviral treatment in order to avoid an invasive approach to the nail lesions. Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Clobetasol; Drug Therapy, Combination; Female; Glucocorticoids; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Mupirocin; Paronychia	1999

Article

Year

Antibiotic Overuse and Paronychia: A Teachable Moment.

JAMA internal medicine, 2016, Volume: 176, Issue:1

Topics: Administration, Cutaneous; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Drug Eruptions; Female; Humans; Inappropriate Prescribing; Mupirocin; Paronychia; Triamcinolone; Trimethoprim, Sulfamethoxazole Drug Combination

2016

Paronychia associated with antiretroviral therapy.

The British journal of dermatology, 1999, Volume: 140, Issue:6

We report six HIV patients who developed painful periungual inflammation of several nails during treatment with the antiretroviral drugs indinavir and lamivudine. The lesions appeared 2-12 months after starting treatment. The occurrence of paronychia in HIV patients has recently been reported in two groups of patients receiving either indinavir or lamivudine. Dermatologists should be aware of this recently reported and probably not uncommon side-effect of antiretroviral treatment in order to avoid an invasive approach to the nail lesions.

Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Clobetasol; Drug Therapy, Combination; Female; Glucocorticoids; HIV Infections; Humans; Indinavir; Lamivudine; Male; Middle Aged; Mupirocin; Paronychia

1999